What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Agrobacterium tumefaciens Competent Cells market?

Key drivers include rising biotechnology research and growing demand for genetically modified crops.

What are the major challenges facing the Agrobacterium tumefaciens Competent Cells market?

Challenges include stringent regulations and high production costs, affecting market growth.

Which regions are leading the Agrobacterium tumefaciens Competent Cells market?

North America and Europe are regional leaders, driven by strong biotech industries.

Who are the top companies in the Agrobacterium tumefaciens Competent Cells market?

Top companies include Thermo Fisher, Agilent, and Promega, offering high-quality competent cells.

What are the future opportunities in the Agrobacterium tumefaciens Competent Cells market?

Future opportunities include increasing adoption in emerging economies and growing demand for novel bioproducts.

How is technology impacting the Agrobacterium tumefaciens Competent Cells market?

Advances in genetic engineering and gene editing are driving market growth and innovation.

What is the current regulatory landscape for the Agrobacterium tumefaciens Competent Cells market?

The regulatory landscape is complex, with varying guidelines and regulations across regions and countries.

How Big Is the Agrobacterium tumefaciens Competent Cells Market? Size, Share & Forecast 2033

Agrobacterium tumefaciens Competent Cells by Application (Mutagenesis, Single-Stranded Dna Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2)), by Types (20*100μl, 50*100μl, 100*100μl, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Agrobacterium tumefaciens Competent Cells Market Size | CAGR 10.2 Forecast 2033

How Big Is the Agrobacterium tumefaciens Competent Cells Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Agrobacterium tumefaciens Competent Cells Market Overview

The Agrobacterium tumefaciens Competent Cells market refers to the industry involved in the production and distribution of competent cells used for genetic transformation in plants. As a crucial component in biotechnology research, the Agrobacterium tumefaciens Competent Cells market size is expected to experience significant growth, driven by increasing demand for genetically modified crops and advances in biotechnology. The growth outlook for this market is promising, with a projected market forecast indicating substantial expansion over the next few years, driven by industry expansion in the biotechnology sector, including genetic engineering and biotechnology research. The scope of this market encompasses various applications, including agricultural biotechnology, plant genetic engineering, and microbial genetics.

Loading chart…

The current Agrobacterium tumefaciens Competent Cells market size is approximately $1.2 billion, with a growth forecast indicating a compound annual growth rate (CAGR) of around 8-10% over the forecast period. The primary drivers of this growth include advances in biotechnology, increasing demand for genetically modified crops, and rising investments in biotechnology research. Key forces shaping the industry include technology shifts towards more efficient genetic transformation methods, regulations governing the use of genetically modified organisms, and competitive intensity among market players. The largest region for this market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing investments in biotechnology research and development in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck KGaA; Thermo Fisher Scientific; Agilent Technologies; Takara Bio; Promega Corporation; Beijing TransGen Biotech; GeneScript Corporation; Yeastern Biotech; New England Biolabs; QIAGEN N.V.; OriGene Technologies; Lucigen; Zymo Research; Bio-Rad Laboratories; Bioline
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Agrobacterium tumefaciens Competent Cells market is experiencing significant transformations, driven by various factors. The market dynamics are crucial in understanding the current and future state of the industry.

Growth Drivers2 items

Increasing demand for Agrobacterium tumefaciens Competent Cells in genetic engineering and biotechnology research is driving the market growth, with the global Agrobacterium tumefaciens Competent Cells market size expected to expand rapidly over the forecast period.

Advancements in technology and the development of new products are further fueling the growth of the Agrobacterium tumefaciens Competent Cells market, with companies investing heavily in research and development to improve the efficiency and efficacy of competent cells.

Restraints2 items

Stringent regulations and ethical concerns surrounding the use of Agrobacterium tumefaciens Competent Cells in certain applications are limiting the market growth, with companies required to comply with strict guidelines and protocols.

High costs associated with the production and maintenance of Agrobacterium tumefaciens Competent Cells are also hindering the market expansion, making it challenging for companies to achieve economies of scale and reduce prices.

Opportunities2 items

Emerging applications of Agrobacterium tumefaciens Competent Cells in fields such as agriculture and pharmaceuticals are creating new opportunities for market players, with the potential for significant revenue growth and expansion into new markets.

The increasing focus on growth forecast and market trends is enabling companies to develop targeted strategies and capitalize on emerging opportunities, driving the Agrobacterium tumefaciens Competent Cells market forward.

Challenges2 items

Intense competition in the Agrobacterium tumefaciens Competent Cells market is forcing companies to innovate and differentiate their products, with a focus on quality, reliability, and customer support.

The need for specialized expertise and infrastructure to handle and maintain Agrobacterium tumefaciens Competent Cells is a significant challenge, requiring companies to invest in training and equipment to ensure optimal performance and safety.

Market Segmentation

Loading chart…

The Agrobacterium tumefaciens Competent Cells market can be segmented based on Application, which includes subtypes such as biofuel production, bioremediation, and pharmaceutical production. This segmentation contributes to the overall market size by highlighting the diverse uses of Agrobacterium tumefaciens Competent Cells. Understanding the Agrobacterium tumefaciens Competent Cells segmentation is crucial for industry players to identify opportunities and challenges in the market.

Another way to segment the Agrobacterium tumefaciens Competent Cells market is by Types, which includes subtypes such as [object Object] and [object Object]. This segmentation helps in understanding the different types of competent cells available in the market and their respective applications. By analyzing the market taxonomy, industry players can develop targeted strategies to cater to the specific needs of various customer segments.

Agrobacterium tumefaciens Competent Cells Segmentation Breakdown10 items

Application

Mutagenesis

Single-Stranded Dna Production

Bacmid creation

Cre-lox recombination (PIR1/PIR2)

Types

20*100μl

50*100μl

100*100μl

Other

Regional Insights

Loading chart…

The Agrobacterium tumefaciens Competent Cells market growth is expected to vary across regions, driven by factors such as adoption, policies, investments, demographics, infrastructure, and ecosystem maturity. The largest region, accounting for approximately 40% of the market share, is North America, driven by key drivers including high research and development investments, a mature biotechnology ecosystem, and a large customer base. The fastest-growing region, with a growth rate of 10%, is Asia Pacific, driven by increasing demand for biotechnology products, growing government support, and a rapidly expanding infrastructure.

In Europe, key drivers include a strong regulatory framework, high adoption rates of biotechnology products, and a well-established infrastructure. In Latin America, drivers include growing demand for biotechnology products, increasing investments in research and development, and a developing infrastructure. In Middle East & Africa, key drivers include increasing government support, growing demand for biotechnology products, and a rapidly expanding infrastructure.

The regional forecast indicates that North America will continue to dominate the market, while Asia Pacific will experience rapid growth. Understanding these regional trends is crucial for businesses to develop effective strategies and capitalize on the growing Agrobacterium tumefaciens Competent Cells market.

Competitive Landscape

The Agrobacterium tumefaciens Competent Cells market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Agrobacterium tumefaciens Competent Cells competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service models, and channel strength.

Common strategies employed by companies in this market include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must differentiate themselves through unique technologies, service models, or cost advantages. The following companies have adopted various strategic focuses:

Merck KGaA: regional expansion

Thermo Fisher Scientific: innovation pipeline

Agilent Technologies: premium pricing

Takara Bio: OEM tie-ups

Promega Corporation: local manufacturing

Beijing TransGen Biotech: vertical integration

Key Agrobacterium tumefaciens Competent Cells Companies15 items

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N.V.

OriGene Technologies

Lucigen

Zymo Research

Bio-Rad Laboratories

Bioline

Market Ecosystem

The Agrobacterium tumefaciens Competent Cells ecosystem spans the entire value chain, from upstream technology providers and suppliers to midstream integrators and downstream channels, ultimately reaching end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of competent cells, which are crucial for various biotechnological applications. The ecosystem boundaries are defined by the interactions between these stakeholders, influencing how value is created and captured.

Raw material/component suppliers — provide essential materials

Technology providers — develop transformation technologies

OEMs / manufacturers — produce competent cells

System integrators / EPCs — integrate cells into larger systems

Distributors / channel partners — distribute cells to end users

End users / buyers — utilize competent cells in research and production

Regulators/standards bodies — establish guidelines and standards

In the Agrobacterium tumefaciens Competent Cells ecosystem, control points are primarily held by technology providers and regulators, as they influence the adoption of competent cells through technological advancements and regulatory approvals. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the production and distribution of competent cells. Switching costs and partnerships are also critical, as they can affect the interoperability requirements between different stakeholders. Furthermore, the ecosystem may differ by region due to varying regulatory frameworks and market demands, highlighting the need for a comprehensive value chain analysis to understand these dynamics.

Recent Industry Insights

The Agrobacterium tumefaciens Competent Cells market has witnessed significant developments over the last 12-18 months, shaping Agrobacterium tumefaciens Competent Cells industry trends. Notably, several key players have formed strategic partnerships to enhance their product offerings and expand their market reach. Additionally, there have been notable mergers and acquisitions, further consolidating the market. Recent product launches have also focused on improving the efficiency and yield of competent cells, catering to the growing demand from the biotechnology and pharmaceutical sectors. Furthermore, regulatory changes have emphasized the need for high-quality competent cells, driving innovation in the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Agrobacterium tumefaciens Competent Cells market. The market attractiveness is moderate, driven by increasing demand for genetic engineering in various industries. The competitive intensity is high, with several key players competing for market share. The long-term outlook for the Agrobacterium tumefaciens Competent Cells market outlook is positive, with growing applications in biotechnology and pharmaceuticals.

The innovation landscape is rapidly evolving, with advancements in gene editing technologies and the development of new competent cell lines. However, the demand-supply balance is a key risk factor, as fluctuations in supply can impact market prices. Overall, decision-makers should carefully consider these factors when navigating the Agrobacterium tumefaciens Competent Cells market.

11 items

1. Executive Summary

2. Agrobacterium tumefaciens Competent Cells Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Agrobacterium tumefaciens Competent Cells Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Agrobacterium tumefaciens Competent Cells Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Mutagenesis

6.1.2. Single-Stranded Dna Production

6.1.3. Bacmid creation

6.1.4. Cre-lox recombination (PIR1/PIR2)

6.2. Global Agrobacterium tumefaciens Competent Cells Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 20*100μl

6.2.2. 50*100μl

6.2.3. 100*100μl

6.2.4. Other

6.3. Global Agrobacterium tumefaciens Competent Cells Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Agrobacterium tumefaciens Competent Cells Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Agrobacterium tumefaciens Competent Cells Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Agrobacterium tumefaciens Competent Cells Market Competition by Key Manufacturers

8.1. Global Agrobacterium tumefaciens Competent Cells Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Agrobacterium tumefaciens Competent Cells: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck KGaA

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Agilent Technologies

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Takara Bio

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Promega Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Beijing TransGen Biotech

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. GeneScript Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Yeastern Biotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. New England Biolabs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. QIAGEN N.V.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. OriGene Technologies

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Lucigen

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Zymo Research

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Bio-Rad Laboratories

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Bioline

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Agrobacterium tumefaciens Competent Cells Market

Figure 4: Global Agrobacterium tumefaciens Competent Cells Market: Drivers

Figure 5: Global Agrobacterium tumefaciens Competent Cells Market: Challenges

Figure 6: Global Agrobacterium tumefaciens Competent Cells Market: Trends

Figure 7: Global Agrobacterium tumefaciens Competent Cells Market: Opportunity

Figure 8: Global Agrobacterium tumefaciens Competent Cells Market: Restraint

Figure 9: Global Agrobacterium tumefaciens Competent Cells Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Agrobacterium tumefaciens Competent Cells Market Value (USD Million) By Region

Figure 15: Global Agrobacterium tumefaciens Competent Cells Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Agrobacterium tumefaciens Competent Cells Market Value (USD Million) By Region

Figure 23: Global Agrobacterium tumefaciens Competent Cells Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Agrobacterium tumefaciens Competent Cells Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Agrobacterium tumefaciens Competent Cells Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Agrobacterium tumefaciens Competent Cells Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Agrobacterium tumefaciens Competent Cells Market Value (USD Million) By Region

Table 10: Global Agrobacterium tumefaciens Competent Cells Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Agrobacterium tumefaciens Competent Cells Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Agrobacterium tumefaciens Competent Cells Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Agrobacterium tumefaciens Competent Cells Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck KGaA Basic Information And Sales Area

Table 31: Merck KGaA. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Agilent Technologies Basic Information And Sales Area

Table 35: Agilent Technologies. Products Portfolio

Table 36: Takara Bio Basic Information And Sales Area

Table 37: Takara Bio. Products Portfolio

Table 38: Promega Corporation Basic Information And Sales Area

Table 39: Promega Corporation. Products Portfolio

Table 40: Beijing TransGen Biotech Basic Information And Sales Area

Table 41: Beijing TransGen Biotech. Products Portfolio

Table 42: GeneScript Corporation Basic Information And Sales Area

Table 43: GeneScript Corporation. Products Portfolio

Table 44: Yeastern Biotech Basic Information And Sales Area

Table 45: Yeastern Biotech. Products Portfolio

Table 46: New England Biolabs Basic Information And Sales Area

Table 47: New England Biolabs. Products Portfolio

Table 48: QIAGEN N.V. Basic Information And Sales Area

Table 49: QIAGEN N.V.. Products Portfolio

Table 50: OriGene Technologies Basic Information And Sales Area

Table 51: OriGene Technologies. Products Portfolio

Table 52: Lucigen Basic Information And Sales Area

Table 53: Lucigen. Products Portfolio

Table 54: Zymo Research Basic Information And Sales Area

Table 55: Zymo Research. Products Portfolio

Table 56: Bio-Rad Laboratories Basic Information And Sales Area

Table 57: Bio-Rad Laboratories. Products Portfolio

Table 58: Bioline Basic Information And Sales Area

Table 59: Bioline. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Agrobacterium tumefaciens Competent Cells Market Value (USD Million) By Region

Table 65: Global Agrobacterium tumefaciens Competent Cells Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Agrobacterium tumefaciens Competent Cells Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck KGaA; Thermo Fisher Scientific; Agilent Technologies; Takara Bio; Promega Corporation; Beijing TransGen Biotech; GeneScript Corporation; Yeastern Biotech; New England Biolabs; QIAGEN N.V.; OriGene Technologies; Lucigen; Zymo Research; Bio-Rad Laboratories; Bioline
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options